Neurizon Therapeutics Limited ABN 35 094 006 023 Prospectus Placement Options Offer: an offer to Placement Participants of one (1) New Option for every one (1) Placement Share issued, or to be issued (subject to Shareholder approval), to them under the Placement. The Closing Date for the Placement...
Prospectus
Filed with ASX · · 58 pages · English
Summary by 6ix AI
Neurizon Therapeutics Limited has filed a prospectus detailing offers for new options to investors, specifically through Placement and SPP Options Offers. The prospectus outlines the terms of these offers, including the requirement for shareholder approval and the intended quotation on the ASX. It emphasizes that the new options are speculative investments and advises potential investors to seek professional advice.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/prospectus-498
Release
Neurizon Therapeutics Limited on 6ix
Story so far
Earlier from Neurizon Therapeutics
- Share Purchase Plan and Options Offer Open
- First Regimen I patient enters Active Treatment Extension
- R&D Facility Extension and Second Drawdown Completed
- Change in substantial holding
- Section 708A Cleansing Statement
Later from Neurizon Therapeutics
- Notice of General Meeting/Proxy Form
- Update - Proposed issue of securities - NUZ
- Bell Potter Healthcare Conference Presentation
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics